A vaccine will be a game-changer for international travel. But it’s not everything

+News

A vaccine will be a game-changer for international travel. But it’s not everything

The Conversation

Sunday 10 January 2021, 12:05 AM

A vaccine alone won’t ensure a safe return to international travel. Image: Ashim D’Silva on Unsplash

We are on our summer break and the editorial office is closed until 18 January. In the meantime, please enjoy our Summer Hiatus series, in which our journalists have selected articles from our 2020 news and clinical archives, The Conversation and other publications with which we share content. Please note the comment function has been turned off while we are away. Happy reading. From Simon Maude: As plans for a trans-Tasman travel bubble crystalise, this 'not-so-fast' The Conversation article says it's all very well having COVID-19 vaccines, but they're no silver bullet when it comes to international air travel

The United Kingdom yesterday became the first country to approve the Pfizer/BioNTech COVID-19 vaccine for widespread use. Following a review by the co

COVID-19

News archive

How to Treat

+How to treat

Polypharmacy

For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews

Wednesday 28 May 2025, 12:50 AM